Postdoctoral Position in Clinical Neurochemistry


Institute of Neuroscience and Physiology


Gothenburg, Sweden


Please apply online at Closing date: 31 January 2013

Applications will be destroyed or returned (upon request) two years after the decision of employment has become final. Applications from the employed and from those who appeal the decision will not be returned. Reference number: PER 2012/299.

For further information, please contact:

Kaj Blennow, Professor
Phone: 031-343 17 91

The University of Gothenburg promotes equal opportunities, equality, and diversity.


The University of Gothenburg is one of the major universities in Europe, with about 38,000 students and a staff of 6,000. The academic work is organized into faculties, a majority of which are based in the central parts of Gothenburg. Education and research are wide-ranging and of high quality—as indicated by both by high numbers of applicants and Nobel prizes received.

The neurochemistry research group is working with clinical studies on neurodegenerative disorders and epidemiological studies on risk factors for neurodegenerative and cerebrovascular disorders. The postdoctorate for this position will work on projects involving production of new monoclonal and polyclonal antibodies as well as new immunochemical analytical methods for protein biomarkers. The work also involves validation of assays as well as analysis of large sample materials of serum/plasma and cerebrospinal fluid from patient cohorts.

Salary is determined on an individual basis. Fixed-term employment, two years. First day of employment: As agreed.


Successful candidates for the position should have earned a Ph.D. degree in a subject relevant for the position. The Ph.D. should not be older than three years.

The postdoctorate is expected to have large knowledge on protein chemistry, production of antibodies, immunoassays, and standardization/validation of analytical methods following clinical chemistry guidelines. Knowledge on disease pathogenesis for neurodegenerative disorders and clinical research is also valuable.